The 12 mg group lost an average of 24.2% body weight at 48 weeks versus 22.8% in the 8 mg group, a difference of 1.4 percentage points
Injectable treatments start at $299 per month, while oral options start at $149 per month
Most patients experience side effects primarily during the first 4 to 8 weeks and find they diminish as the dose stabilizes
14 The increased fat accumulation, or steatosis, in the pancreas induces chronic inflammation, predisposing to acute pancreatitis
This convenience enhances adherence to the treatment regimen, which is a critical factor in achieving and maintaining weight loss
There are a variety of reasons why people respond differently to GLP-1 medications, including demographic, body composition, health, lifestyle and environmental factors